BIO
Dr David Rabbolini is a haematologist who specialises in conditions related to bleeding and blood clotting.
Dr David John Rabbolini
BSc MBBCh PhD FRACP FRCPA
David is a haematologist who specialises in conditions related to bleeding and blood clotting.
He has trained and practiced in tertiary centres of excellence in Australia and the UK (Oxford), as well as in rural and regional centres in South Africa and Australia. Having obtained his PhD (Sydney) exploring rare bleeding disorders and through his continued involvement in clinical and translational research, David continues to play an active role in the development of his field.
David believes that optimal health can be achieved through simple measures that include diet, exercise, and spiritual practice. In the setting of illness he believes in the importance of an individualised and integrated approach using the best available cutting-edge diagnostics and contemporary medicines. David places an emphasis on informed and shared decision making to achieve the best outcomes for his patients.
AFFILIATIONS
HONORARY SENIOR LECTURER
The Kolling Institute
Faculty of Medicine and Health
The University of Sydney
CO-LEAD
The Sydney Platelet Group
(research collaborative)
SPEAKER CONTRIBUTIONS
SPEAKER CONTRIBUTIONS
Dr Rabbolini’s experience has been recognised by his peers, and he has been an invited speaker at 13 national and international (UK, Spain and Kenya) conferences and workshops in the last 5 years and has moderated an International Society of Thrombosis and Haemostasis (ISTH) led webinar on Genetics in haemostasis and thrombosis. Dr Rabbolini is actively engaged in research and education and his contributions have been recognised through invitations on a national and international stage. Notable speaker roles have included:
2022
Invited Speaker (State-of-the art session) – ISTH Congress 2022, London, UK .
2021
63rd Annual Meeting of the Spanish Society of Haematology and Haemotherapy and 37th National Congress of the Spanish Society of Thrombosis and Haemostasis, (Pamplona, Spain, virtual).
Topic: Inherited Platelet Disorders, Australian Experience: From Clinical Practice to Translational Research.
2020
Invited moderator – ISTH webinar – Genetics in haemostasis and thrombosis (virtual)
2018
ISTH/ KSTH, (Nairobi, Kenya)
Topics: a) How to approach a patient with a history of increased bleeding tendency? Focus on platelet disorders
- b) Inherited thrombophilia rational for not testing
- c) HITS diagnosis and treatment
- d) ROTEM – practical applications.
2016
ISTH Advanced Training Course in Thrombosis and Haemostasis, (Oxford, England)
Topics: a) Genetic Testing in Inherited Thrombocytopenia: An Australasian Perspective.
- b) iPS Cell Technology and Disease Modeling
2022
Pathology update meeting, (Sydney, Australia).
2021
AHCDO education seminar (virtual, Sydney, Australia)
Topic: The Sydney Platelet Group
2019
National haematology weekend (sponsored by Alexion),( Melbourne, Australia).
Topic: Platelets: new innovations.
2019
Blood Annual Scientific meeting, (Perth, Australia)
Topic: The role of NGS in platelet disorders
2019
HSANZ Scientific meeting, NSW branch (Sydney, Australia)
Topic: An update from the collaborative research group – The Sydney Platelet Group
2019
South Australia blood club annual conference (Adelaide, Australia)
Topics: a) Phenotyping and genotyping platelet disorders: establishing a phenotype
- b) Phenotyping and genotyping platelet disorder: establishing a genotype
2019
Queensland coagulation challenges meeting (Brisbane, Australia)
Topic: Investigating Platelet disorders
2019
NSW RCPA registrar training course (Sydney, Australia)
Topic: Platelet physiology and functional testing
2018
Haemostasis update weekend, (Melbourne, Australia).
Topic: Platelet function testing
2017
HAA 2017, (Sydney, Australia)
Topic: integrated pathways for the diagnosis of inherited platelet disorders
2017
Coagulation Challenges Meeting, (Sydney, Australia)
Topic: HITS: Diagnosis and Management
2016
ASTH workshop 2016, (Melbourne, Australia)
Topic: New and emerging technologies in haematology
2016
HAA 2016, (Melbourne, Australia)
Topic: Genetic testing in the investigation of patients with uncharacterised thrombocytopenia.
2016
HSANZ scientific meeting 2016, Western Australia Branch (Perth, Australia)
Topics: a) Platelet disorders: From bench to bedside
- b) iPS cells: Future clinical applications
2016
Canberra Haematology Department Monthly Scientific Meeting (Canberra, Australia)
Topic: a) iPS cells – disease modelling
2016
ASTH “Sydney clotters” meeting (Sydney, Australia)
Topic: a) Transcription factors in inherited platelet disorders: clinical phenotypes and diagnostic considerations.
2015
ASTH scientific workshop, (Adelaide, Australia)
Topic: DNA-based diagnosis of uncharacterised inherited macrothrombocytopenias using next generation sequencing technology
2015
Coagulation Challenges Meeting, (Sydney, Australia)
Topic: Investigation of Inherited Platelet function disorders
2014
HSANZ Scientific meeting, NSW branch (Sydney, Australia)(May 2014)
Topic: An approach to inherited platelet disorders.
NATIONAL
2021
HAA Blood meeting, (Adelaide, Australia, virtual)
ASTH: free communications session at the HAA annual scientific meeting.
Abstract title: Treatment of Immune Thrombocytopenia (ITP)- a Multi-Centre Retrospective Review. Senior author. Presented by Dr Adam Rosenberg.
2018
HAA blood meeting, (Brisbane, Australia).
ASTH: free communications session at the HAA annual scientific meeting.
Abstract title: An integrated approach to inherited platelet disorders: Results from a research collaborative, the Sydney Platelet Group. Author.
2016
HAA Blood meeting (Melbourne, Australia): Combined HSANZ and ASTH Presidential Symposium at the HAA annual scientific meeting
Abstract title: Platelet development and bleeding phenotype is altered with Mutation in different zinc finger domains of GFI1B transcription factor.
2015
HAA annual scientific meeting, (Adelaide, Australia).
ASTH: free communications session.
Abstract title: A homozygous mutation in the transcription factor FLI1 causes giant platelet alpha-granule formation similar to that observed in Paris-Trousseau thrombocytopenia.
2012
RCPA Pathology Update conference, (Sydney, Australia).
Abstract title: Haematology registrar presentation (case study, Hypocellular MDS)
RESEARCH & PUBLICATIONS
RESEARCH & PUBLICATIONS
David has been successful in contributing to the field through a total of 26 publications (senior author 4; first author 11; second author 10 and middle author 1). Collectively, his work has focused on improving the diagnosis and management of platelet related bleeding disorders through descriptions of his experience using genetic sequencing technologies to diagnose these disorders, and via reports detailing phenotypic characteristics and pathophysiological mechanisms of specific disorders caused by pathological genetic variants in genes associated with bleeding. For further information, view Research Interests and Publications.
